EU/3/11/849 - orphan designation for prevention of cytomegalovirus disease in patients with impaired cell-mediated immunity
(S)-{8-Fluoro-2-2[4-(3-methoxyphenyl)-1-piperazinyl]-3-[2-methoxy-5-(trifluoromethyl)-phenyl]-3, 4-dihydro-4-quinazolinyl} acetic acid (letermovir)
Orphan
Human